PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TBIO vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between TBIO and XLV is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

TBIO vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Telesis Bio Inc. (TBIO) and Health Care Select Sector SPDR Fund (XLV). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2025February
-88.99%
-4.57%
TBIO
XLV

Key characteristics

Sharpe Ratio

TBIO:

-0.37

XLV:

0.22

Sortino Ratio

TBIO:

0.02

XLV:

0.38

Omega Ratio

TBIO:

1.00

XLV:

1.05

Calmar Ratio

TBIO:

-0.93

XLV:

0.19

Martin Ratio

TBIO:

-1.21

XLV:

0.49

Ulcer Index

TBIO:

76.59%

XLV:

5.01%

Daily Std Dev

TBIO:

249.04%

XLV:

11.43%

Max Drawdown

TBIO:

-99.93%

XLV:

-39.17%

Current Drawdown

TBIO:

-99.90%

XLV:

-6.12%

Returns By Period

In the year-to-date period, TBIO achieves a -0.02% return, which is significantly lower than XLV's 6.42% return.


TBIO

YTD

-0.02%

1M

-4.79%

6M

-88.98%

1Y

-92.95%

5Y*

N/A

10Y*

N/A

XLV

YTD

6.42%

1M

4.44%

6M

-4.57%

1Y

2.48%

5Y*

8.95%

10Y*

9.11%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TBIO vs. XLV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TBIO
The Risk-Adjusted Performance Rank of TBIO is 2222
Overall Rank
The Sharpe Ratio Rank of TBIO is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of TBIO is 3333
Sortino Ratio Rank
The Omega Ratio Rank of TBIO is 3232
Omega Ratio Rank
The Calmar Ratio Rank of TBIO is 22
Calmar Ratio Rank
The Martin Ratio Rank of TBIO is 1414
Martin Ratio Rank

XLV
The Risk-Adjusted Performance Rank of XLV is 1111
Overall Rank
The Sharpe Ratio Rank of XLV is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of XLV is 1010
Sortino Ratio Rank
The Omega Ratio Rank of XLV is 1010
Omega Ratio Rank
The Calmar Ratio Rank of XLV is 1313
Calmar Ratio Rank
The Martin Ratio Rank of XLV is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TBIO vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Telesis Bio Inc. (TBIO) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TBIO, currently valued at -0.37, compared to the broader market-2.000.002.00-0.370.22
The chart of Sortino ratio for TBIO, currently valued at 0.02, compared to the broader market-4.00-2.000.002.004.006.000.020.38
The chart of Omega ratio for TBIO, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.05
The chart of Calmar ratio for TBIO, currently valued at -0.93, compared to the broader market0.002.004.006.00-0.930.19
The chart of Martin ratio for TBIO, currently valued at -1.21, compared to the broader market0.0010.0020.0030.00-1.210.49
TBIO
XLV

The current TBIO Sharpe Ratio is -0.37, which is lower than the XLV Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of TBIO and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
-0.37
0.22
TBIO
XLV

Dividends

TBIO vs. XLV - Dividend Comparison

TBIO has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.57%.


TTM20242023202220212020201920182017201620152014
TBIO
Telesis Bio Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund
1.57%1.67%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%

Drawdowns

TBIO vs. XLV - Drawdown Comparison

The maximum TBIO drawdown since its inception was -99.93%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for TBIO and XLV. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.90%
-6.12%
TBIO
XLV

Volatility

TBIO vs. XLV - Volatility Comparison

Telesis Bio Inc. (TBIO) has a higher volatility of 81.49% compared to Health Care Select Sector SPDR Fund (XLV) at 4.11%. This indicates that TBIO's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%140.00%SeptemberOctoberNovemberDecember2025February
81.49%
4.11%
TBIO
XLV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab